Medicine & Life Sciences
DNA Vaccines
100%
T-Lymphocytes
59%
Vaccination
56%
Human papillomavirus 16
51%
Papillomavirus Vaccines
48%
Calreticulin
35%
DNA
32%
Neoplasms
29%
CD8 Antigens
24%
Vaccine Potency
19%
Antigens
18%
Vaccines
17%
Electroporation
17%
Epitopes
17%
Uterine Cervical Neoplasms
17%
HLA-A2 Antigen
16%
Capsid Proteins
16%
Therapeutic Uses
15%
Papillomavirus Infections
15%
T-Lymphocyte Epitopes
15%
Transgenic Mice
14%
Immunity
14%
Virion
13%
Dendritic Cells
13%
Peptides
13%
GPI0100
12%
Piperidones
11%
Proteasome Endopeptidase Complex
10%
Human papillomavirus 11
10%
Immunotherapy
10%
Cytotoxic T-Lymphocytes
10%
Merkel cell polyomavirus
10%
RA190
9%
Vaccinia
9%
Squamous Cell Carcinoma of Head and Neck
9%
Inbred C57BL Mouse
9%
Antigen Presentation
9%
Therapeutics
9%
Proteins
8%
Furin
8%
Major Histocompatibility Complex
8%
Immunization
8%
Antibodies
8%
Amyloid Precursor Protein Secretases
7%
Oncogene Proteins
7%
Intramuscular Injections
7%
Ubiquitin
7%
Cellular Immunity
6%
Merkel Cell Carcinoma
6%
Cervical Intraepithelial Neoplasia
6%
Agriculture & Biology
Papillomaviridae
25%
recombinant vaccines
22%
Human papillomavirus type 16
17%
T-lymphocytes
17%
calreticulin
11%
vaccination
10%
antigens
10%
neoplasms
8%
mice
7%
dendritic cells
7%
Human polyomavirus 5
7%
Mus musculus
6%
papilloma
5%
vaccines
5%
DNA
5%
immune response
5%
Severe acute respiratory syndrome coronavirus
5%